Commonwealth Equity Services, LLC Idera Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$0.23 - $0.43 $201 - $376	875 Added 1.01%	87,412 $30,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.53 $47 - $66	-125 Reduced 0.14%	86,537 $32,000
Q2 2021 Aug 11, 2021	BUY	$1.01 - $1.58 $49,616 - $77,617	49,125 Added 130.87%	86,662 $103,000
Q1 2021 May 04, 2021	BUY	$1.23 - $5.98 $13,376 - $65,032	10,875 Added 40.79%	37,537 $48,000
Q4 2020 Feb 11, 2021	BUY	$2.09 - $5.18 $12,017 - $29,785	5,750 Added 27.5%	26,662 $97,000
Q3 2020 Nov 05, 2020	SELL	$1.71 - $2.68 $5 - $8	-3 Reduced 0.01%	20,912 $44,000
Q1 2020 May 11, 2020	SELL	$1.06 - $2.15 $26 - $53	-25 Reduced 0.12%	20,915 $27,000
Q2 2019 Jul 19, 2019	BUY	$2.37 - $3.97 $4,242 - $7,106	1,790 Added 9.35%	20,940 $55,000
Q3 2018 Nov 06, 2018	BUY	$5.53 - $11.36 $105,899 - $217,544	19,150 New	19,150 $170,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Commonwealth Equity Services, LLC with notifications on news.